"Check 41 Witnesses And Hold Cases," Bareskrim Immediately Confirmed The Suspect In The Case Of Accounting For Acute Kid Failure

The Criminal Investigation Unit of the National Police examined 41 witnesses related to the investigation of cases of acute kidney failure in children suspected to have been due to the drugs contaminated with Etylene Glikol (EG) and Dietilen Glikol (DEG) exceeding the threshold by pharmaceutical companies.

"Bareskrim Polri has examined 41 people, consisting of 31 witnesses and 10 expert witnesses," said Head of the Public Information Bureau (Karopenmas) of the Public Relations Division of the National Police Brigadier General Pol Ahmad Ramadhan, in Jakarta, quoted from Antara, Thursday, November 17.

Ramadhan explained that investigators continue to investigate suppliers or suppliers of medicinal raw materials for Propilen Glikol (PG) containing additional EG and DEG materials to PT Afi Farma (AF), the drug manufacturer Parachetamol.

"Because PT. AF is suspected of not only receiving raw materials from one company, but is suspected to have come from several companies. This is what investigators are now investigating," he said.

For the determination of the suspect, he continued, it will be carried out through a case title process that will be carried out as soon as possible by investigators.

Separately, the Director of Certain Economic Crimes (Dirtipidter) of the Criminal Investigation Unit of the National Police Brigadier General Pol. Pipit Rismanto said that his party had finished carrying out the case title on Wednesday, November 16.

From the results of the case, investigators have pocketed potential suspects in cases of acute kidney failure that killed more than 100 children in various regions in Indonesia.

According to Pipit, his party announced the suspect in the case as soon as possible after receiving instructions from the leadership of the National Police. "The case was completed yesterday, it was announced immediately," said Pipit.

Pipit added that the investigation was carried out in stages, starting from a pharmaceutical company first, and continuing to investigate who was responsible for the drugs to the public.